Characterization of tertiary lymphoid structures and its association with response to immune checkpoint inhibitors in triple negative breast cancer using spatial transcriptomics

被引：1
|
作者：
Wang, Xiaoxiao
Venet, David
Lifrange, Frederic
Larsimont, Denis
Rediti, Mattia
Stenbeck, Linnea
Dupont, Floriane
Rouas, Ghizlane
Garcia, Andrea Joaquin
Gacquer, David
Craciun, Ligia
Buisseret, Laurence
Bhalla, Nayanika
Masarapu, Yuvarani
Thrane, Kim
Villacampa, Eva Gracia
Franzen, Lovisa
Saarenpaa, Sami
Kvastad, Linda
Lundeberg, Joakim
Rothe, Francoise
Sotiriou, Christos
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-25-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-25-07
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Immune microenvironment spatial landscapes of tertiary lymphoid structures in gastric cancer
    Xie, Yi
    Peng, Haoxin
    Hu, Yajie
    Jia, Keren
    Yuan, Jiajia
    Liu, Dan
    Li, Yanyan
    Feng, Xujiao
    Li, Jian
    Zhang, Xiaotian
    Sun, Yu
    Shen, Lin
    Chen, Yang
    BMC MEDICINE, 2025, 23 (01):
  • [32] Developing an immune signature for triple-negative breast cancer to predict prognosis and immune checkpoint inhibitor response
    Wang, Ce
    Feng, Guoshuang
    Zhu, Jingjing
    Wei, Kecheng
    Huang, Chen
    Wu, Zhenyu
    Yu, Yongfu
    Qin, Guoyou
    FUTURE ONCOLOGY, 2022, 18 (09) : 1055 - 1066
  • [33] Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinoma
    Ruiz-Torres, Daniel A.
    Bryan, Michael E.
    Hirayama, Shun
    Merkin, Ross D.
    Luciani, Evelyn
    Roberts, Thomas J.
    Patel, Manisha
    Park, Jong C.
    Wirth, Lori J.
    Sadow, Peter M.
    Sade-Feldman, Moshe
    Stott, Shannon L.
    Faden, Daniel L.
    ONCOIMMUNOLOGY, 2025, 14 (01):
  • [34] Tertiary lymphoid structures: Prognostic significance and relationship with tumor-infiltrating lymphocytes in triple negative breast cancer
    Park, In Ah
    Lee, Hee Jin
    Song, In Hye
    Kim, Joo Young
    Yu, Jong Han
    Gong, Gyungyub
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [35] Spatial mapping of the immune microenvironment in primary triple-negative breast cancer (TNBC) and association with neoadjuvant therapy response
    Telli, M. L.
    Vinayak, S.
    Khododoust, M. S.
    Gruber, J. J.
    Ford, J. M.
    Sanchez, P.
    Banayan, N.
    Azimi, S.
    Tumeh, P. C.
    Newman, A. M.
    Alizadeh, A. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [36] Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation
    Romero-Cordoba, Sandra
    Meneghini, Elisabetta
    Sant, Milena
    Iorio, Marilena Valeria
    Sfondrini, Lucia
    Paolini, Biagio
    Agresti, Roberto
    Tagliabue, Elda
    Bianchi, Francesca
    CANCERS, 2019, 11 (07)
  • [37] Harnessing the gut microbiome to modulate immune checkpoint blockade response in triple-negative breast cancer
    Clear, Kenysha Y. J.
    Wilson, Adam S.
    Stirling, Elizabeth R.
    Tsai, Yu-Ting
    Payne, Valerie
    Soto-Pantoja, David R.
    Cook, Katherine L.
    CANCER RESEARCH, 2024, 84 (06)
  • [38] Positive progress: current and evolving role of immune checkpoint inhibitors in metastatic triple-negative breast cancer
    Simmons, Christine E.
    Brezden-Masley, Christine
    McCarthy, Joy
    McLeod, Deanna
    Joy, Anil Abraham
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [39] Immune checkpoint inhibitors for triple-negative inflammatory breast cancer (INCORPORATE): an international multicenter retrospective analysis
    Valenza, Carmine
    Trapani, Dario
    Zagami, Paola
    Antonarelli, Gabriele
    Bielo, Luca Boscolo
    Nicolo, Eleonora
    Ribeiro, Joana Mourato
    Guidi, Lorenzo
    Reduzzi, Carolina
    Spotti, Martina
    Munzone, Elisabetta
    Cortes, Javier
    Pistilli, Barbara
    Tolaney, Sara
    Ueno, Naoto
    Layman, Rachel
    Cristofanilli, Massimo
    Carey, Lisa
    Lynce, Filipa
    Woodward, Wendy
    Curigliano, Giuseppe
    CANCER RESEARCH, 2024, 84 (09)
  • [40] Use of Immune Checkpoint Inhibitors in Early Triple-Negative Breast Cancer: Beyond the Early Conflicting Results
    Din, Mohammad Ammad Ud
    Jamshed, Saad
    Patel, Mehul
    CLINICAL BREAST CANCER, 2021, 21 (03) : 153 - 155
12345